Dyno Therapeutics To Accelerate Design Of High-performance Biological Sequences Using Nvidia Ai

Dyno Therapeutics and NVIDIA are collaborating to advance biological sequence design using Dyno’s AI and in vivo experimentation capabilities and NVIDIA’s BioNeMo platform. This partnership aims to improve outcomes in healthcare and technology by leveraging AI-powered sequence design algorithms and NVIDIA’s accelerated computing resources.